Prospective, Single Arm, Single Center Study of Duvelisib Combined With Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma (PTCL)

Abroad (travel likely)RecruitingPHASE2

Conditions

Newly Diagnosed Peripheral T-cell Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Contact: Study coordinator (Liling Zhang, M.D) · lily1228@sina.com · 0086 27 83262660
Contact: Principal Investigator (Liling Zhang, M.D)

Study leads

Liling Zhang, M.D
Principal Investigator
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)

T-cell Acute Lymphoblastic Leukemia · T-cell Lymphoma · Mixed Phenotype Acute Leukemia

Abroad (travel likely)RecruitingPHASE2

San Diego, United States · Charlotte, United States

Golidocitinib Plus CHOP in Newly Diagnosed PTCL

Peripheral T-cell Lymphoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beijing, China

Concurrent Tislelizumab and Radiotherapy in Newly Diagnosed Extranodal NK/T-cell Lymphoma, Nasal Type

Lymphoma

Abroad (travel likely)RecruitingPHASE2

Seoul, South Korea

Clinical Study of XPO1 Inhibitor Selinexor Combined With COPL in Newly Diagnosed Advanced NK/T-cell Lymphoma

nk/T-cell Lymphoma · Newly Diagnosed · Advanced Lymphoma

Abroad (travel likely)RecruitingPHASE2

Beijing, China